Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 18:08 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
NCT05942911 · Incannex Healthcare Ltd · PHASE2 · terminated · last registry update 2026-03-27 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Recruitment challenges” | – | Registry record, Incannex Healthcare Ltd |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CNR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-10-29Results posted on the registry: University of Utah, Cannabidiol + Placebo (NCT04044729)
- 2026-10-28Results posted on the registry: VA Office of Research and Development, Cannabidiol + placebo (NCT03518801)
- 2026-10-16Also stopped (terminated): University Hospital Schleswig-Holstein, Cannabisextrakt Avextra 10/10 Lösung (NCT06097533)
- 2026-10-06Also stopped (terminated): Medical University of South Carolina, Dronabinol + Placebo (NCT07225777)
- 2026-09-30Results posted on the registry: Indiana University, Tacrolimus single dose + Epidiolex single dose (NCT05490511)
- 2026-09-25Also stopped (withdrawn): Foundation for Orthopaedic Research and Education, Cannabidiol Oil (NCT05934500)
- 2026-09-08Results posted on the registry: McMaster University, MPL-001 (CBD: THC 25:1) + Placebo oil for oral use (NCT03825965)
- 2026-09-01Results posted on the registry: University of California, San Diego, Purysis CBD + Placebo (NCT05832281)
- 2026-09-01Also stopped (terminated): University of California, San Diego, Purysis CBD + Placebo (NCT05832281)
- 2026-08-28Results posted on the registry: Wake Forest University Health Sciences, a drug against CNR1 (NCT06800066)
- 2026-08-19Also stopped (withdrawn): Kanako Hayashi, Cannabis plant (THC 20mg) + Cannabis (0%/ THC / 0% CBD) (NCT06755346)
- 2026-07-29Results posted on the registry: University of Chicago, Cannabidiol (NCT04978428)
- 2026-07-28Also stopped (terminated): Simon Ducharme, MD, Nabilone + Placebo (NCT05742698)
- 2026-07-24Results posted on the registry: Centre for Addiction and Mental Health, alcohol + placebo alcohol (NCT03106363)
- 2026-07-23Phase 3 first posted: Jazz Pharmaceuticals, CBD-OS + Placebo (NCT07723976)
- 2026-07-14Also stopped (suspended): City of Hope Medical Center, BRC-001 + Placebo Administration (NCT06538389)
- 2026-07-09Results posted on the registry: University of Chicago, delta-9-tetrahydrocannabinol (THC) (5) + Placebo (NCT06471647)
- 2026-06-25Phase 3 first posted: UMC Utrecht, Cannabidiol (CBD) oral solution (NCT07668856)
- 2026-06-18Results posted on the registry: Yasmin Hurd, Placebo + Cannabidiol (CBD) 200mg (NCT06206291)
- 2026-06-17Results posted on the registry: Cardiol Therapeutics Inc., CardiolRx (NCT05180240)
- 2026-06-12Phase 3 first posted: PleoPharma, Inc., PP-01 + Nabilone (NCT07644052)
- 2026-06-12Also stopped (terminated): Hôpital le Vinatier, Cannabidiol oral oil + Placebo oral oil (NCT05159830)
- 2026-05-26Results posted on the registry: Hospital for Special Surgery, New York, cannabidiol (NCT04749628)
- 2026-05-07Results posted on the registry: Eric Hollander, CBDV Compound + Placebo (NCT03848481)
- 2026-05-07Also stopped (terminated): Eric Hollander, CBDV Compound + Placebo (NCT03848481)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision